By 
London stocks rise on upbeat AstraZeneca results; BOJ stokes rate worries By Reuters
Breaking News
‘;
Published Jul 28, 2023 08:29
Updated Jul 28, 2023 09:35
© Reuters. FILE PHOTO: The London Stock Exchange Group offices are seen in the City of London, Britain, December 29, 2017. REUTERS/Toby Melville/File Photo
By Shubham Batra and Sruthi Shankar
(Reuters) -British equities edged higher on Friday on strong gains in the pharmaceutical sector driven by upbeat quarterly results from AstraZeneca (NASDAQ:AZN), although surprise Bank of Japan’s yield control policy tweak spurred worries of higher interest rates.
The blue-chip FTSE 100 added 0.2%, hovering around its highest level in nine weeks. Meanwhile, the midcap FTSE 250 index fell 0.5% after rising for three consecutive sessions.
The biggest gainer on the FTSE was the pharmaceutical sector, which jumped 2.5% after AstraZeneca beat expectations for its second-quarter profit. The stock climbed 4.0%.
The biopharmaceutical company also said on Friday its unit Alexion (NASDAQ:ALXN) has agreed to buy U.S. drugmaker Pfizer (NYSE:PFE)’s early-stage rare disease gene therapy portfolio for up to $1 billion, plus royalties on sales.
Rate-sensitive real estate sector lost 0.5% as UK 10-year gilt yield rose to 4.392%, its highest since July 18, after the BOJ tweaked its yield control policy during its monetary policy review.
The BOJ maintained its ultra-low interest rates but shifted slightly on yield curve control, saying its 0.5% limit on 10-year government bond yields was now a “reference” and offered to buy such bonds at 1% in the market instead.
“”We think the move is an acknowledgement of the changing macro environment and effectively raises the upper bound limit,” said Mark Haefele, chief investment officer, UBS Global Wealth Management.
Standard Chartered (LON:STAN) Plc rose 6.2% after the Asia-focussed lender upgraded its annual profit forecast and set a new $1 billion share buyback after a strong first-half performance.
Crisis-hit NatWest (LON:NWG) added 0.1% after the lender posted forecast-beating first half profit as it reels from the abrupt departure of its CEO Alison Rose over a public spat with former Brexit party leader Nigel Farage.
British Airways (LON:ICAG) operator IAG gained 2.5% as its quarterly profit beat analyst forecasts by 40% and it said it was encouraged by the outlook for the summer.
London stocks rise on upbeat AstraZeneca results; BOJ stokes rate worries
Terms And Conditions
Privacy Policy
Risk Warning
Do not sell my personal information
© 2007-2023 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Comments